Abstract
We reported one patient with Charcot-Marie-Tooth type 4C (CMT4C) who developed seropositive myasthenia gravis. Neuromuscular junction alterations in CMT4C patients have not yet been reported. However, few patients have been reported to simultaneously have MG and CMT, but none with CMT4C. Our report suggests that additional research is required to confirm whether genetic neuropathies may predispose to MG.
References
Houlden H, Laura M, Ginsberg L, Jungbluth H, Robb SA, Blake J, Robinson S, King RH, Reilly MM (2009) The phenotype of Charcot-Marie-Tooth disease type 4C due to SH3TC2 mutations and possible predisposition to an inflammatory neuropathy. Neuromuscul Disord 19:264–269
Cipriani S, Phan V, Medard JJ, Horvath R, Lochmuller H, Chrast R, Roos A, Spendiff S (2018) Neuromuscular junction changes in a mouse model of Charcot-Marie-Tooth disease type 4C. Int J Mol Sci 19:E4072
Chen CM, Chang HS, Lyu RK, Tang LM, Chen ST (1997) Myasthenia gravis and Charcot-Marie-Tooth disease type 1A: an unusual combination of diseases. Muscle Nerve 20:1457–1459
Berger JR, Ayyar DR, Kimura I, Kovacs A (1985) Myasthenia gravis complicating Charcot-Marie-Tooth disease: report of a case. J Clin Neuro-ophthalmol 5:76–80
Salemi G, Fierro B, Savettieri G, Maggio M, Lupo I, Ferrari S, Piccoli F (1992) Myasthenia gravis associated with Charcot-Marie-Tooth neuropathy: report of a case. Ital J Neurol Sci 13:431–433
Ang ET, Schafer R, Baltensperger R, Wernig A, Celio M, Oliver SS (2010) Motor axonal sprouting and neuromuscular junction loss in an animal model of Charcot-Marie-Tooth disease. J Neuropathol Exp Neurol 69:281–293
Sleigh JN, Grice SJ, Burgess RW, Talbot K, Cader MZ (2014) Neuromuscular junction maturation defects precede impaired lower motor neuron connectivity in Charcot-Marie-Tooth type 2D mice. Hum Mol Genet 23:2639–2650
Spaulding EL, Sleigh JN, Morelli KH, Pinter MJ, Burgess RW, Seburn KL (2016) Synaptic deficits at neuromuscular junctions in two mouse models of Charcot-Marie-Tooth Type 2d. J Neurosci 36:3254–3267
Acknowledgements
The laboratory team of the Mendelics for their collaboration in the NGS panel analysis. This study was supported by UFPR and genetic analysis (NGS panel) was partially supported by PTC Therapeutics Brazil.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
This report was published with written patient consent. All studies were conducted in accordance with ethical principles after obtaining patient consent. The study was approved by the Local Ethics Committee for Human Research of the Hospital de Clínicas da Universidade Federal do Paraná (UFPR).
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Lorenzoni, P.J., Kay, C.S.K., Ducci, R.DP. et al. Charcot-Marie-Tooth disease type 4C associated with myasthenia gravis: coincidental or a foreseeable association?. Neurol Sci 43, 705–707 (2022). https://doi.org/10.1007/s10072-021-05591-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-021-05591-7